{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:02:38Z","timestamp":1792785758614,"version":"4.5.0"},"reference-count":102,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Collaborative Research Fund of Research Grants Council","award":["C7015-23G"],"award-info":[{"award-number":["C7015-23G"]}]},{"name":"collaborative research","award":["2207101590"],"award-info":[{"award-number":["2207101590"]}]},{"name":"basic research","award":["2201101499"],"award-info":[{"award-number":["2201101499"]}]},{"name":"University of Hong Kong, and startup funds","award":["207051059"],"award-info":[{"award-number":["207051059"]}],"id":[{"id":"https:\/\/ror.org\/02zhqgq86","id-type":"ROR","asserted-by":"crossref"}]},{"name":"University of Hong Kong, and startup funds","award":["6010309"],"award-info":[{"award-number":["6010309"]}],"id":[{"id":"https:\/\/ror.org\/02zhqgq86","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Faculty of Dentistry, the University of Hong Kong","id":[{"id":"https:\/\/ror.org\/02zhqgq86","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Therapeutic antibodies are a major class of medicines, but high target affinity alone does not ensure manufacturability, stability, safety, or clinical success. Developability has therefore become a central constraint in antibody engineering and has pushed the field beyond affinity-first screening toward multi-objective decision-making. Machine-learning-based models increasingly integrate antibody sequence, structure, interaction, and assay data to estimate properties such as affinity, specificity, aggregation, viscosity, solubility, stability, immunogenicity, and pharmacokinetics before experimental testing. In practice, these models are most useful when they help prioritize experiments rather than replace empirical evaluation. Here, we review the data resources used for antibody developability modeling, the main classes of property predictors, and optimization frameworks that balance competing design objectives. We cover Pareto optimization, Bayesian optimization, active learning, and conditional generative modeling, and discuss how these approaches are being adapted to bispecific antibodies and nanobodies. We argue that AI is most useful when model outputs are interpreted in the context of assay design, uncertainty, and antibody format, and when they are used to guide candidate selection and experimental design rather than serve as stand-alone surrogates for developability.<\/jats:p>","DOI":"10.1093\/abt\/tbag039","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:11:14Z","timestamp":1785323474000},"page":"508-520","source":"Crossref","is-referenced-by-count":0,"title":["Beyond affinity: AI-supported developability assessment and multi-objective optimization in antibody development"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2690-7583","authenticated-orcid":false,"given":"Qianhui","family":"Jiang","sequence":"first","affiliation":[{"name":"Division of Applied Oral Sciences and Community Dental Care, Faculty of Dentistry, The University of Hong Kong , 34 Hospital Road, Hong Kong SAR,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Guan","sequence":"additional","affiliation":[{"name":"Division of Applied Oral Sciences and Community Dental Care, Faculty of Dentistry, The University of Hong Kong , 34 Hospital Road, Hong Kong SAR,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yu","sequence":"additional","affiliation":[{"name":"Division of Applied Oral Sciences and Community Dental Care, Faculty of Dentistry, The University of Hong Kong , 34 Hospital Road, Hong Kong SAR,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Singh","sequence":"additional","affiliation":[{"name":"Division of Applied Oral Sciences and Community Dental Care, Faculty of Dentistry, The University of Hong Kong , 34 Hospital Road, Hong Kong SAR,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Pelekos","sequence":"additional","affiliation":[{"name":"Division of Periodontology & Implant Dentistry, Faculty of Dentistry, The University of Hong Kong , 34 Hospital Road, Hong Kong SAR,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward Chin Man","family":"Lo","sequence":"additional","affiliation":[{"name":"Division of Applied Oral Sciences and Community Dental Care, Faculty of Dentistry, The University of Hong Kong , 34 Hospital Road, Hong Kong SAR,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4432-4707","authenticated-orcid":false,"given":"Junwen","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Applied Oral Sciences and Community Dental Care, Faculty of Dentistry, The University of Hong Kong , 34 Hospital Road, Hong Kong SAR,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"2026100105270889200_ref1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s43556-022-00100-4","article-title":"Development of therapeutic antibodies for the treatment of diseases","volume":"3","author":"Wang","year":"2022","journal-title":"Mol Biomed"},{"key":"2026100105270889200_ref2","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1186\/s12951-024-02900-y","article-title":"Discovery of nanobodies: A comprehensive review of their applications and potential over the past five years","volume":"22","author":"Alexander","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"2026100105270889200_ref3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/abt\/tbaf014","article-title":"Structure and function of therapeutic antibodies approved by the US FDA in 2024","volume":"8","author":"Strohl","year":"2025","journal-title":"Antib Ther"},{"key":"2026100105270889200_ref4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/d41573-026-00001-z","article-title":"2025 FDA approvals","volume":"25","author":"Mullard","year":"2026","journal-title":"Nat Rev Drug Discov"},{"key":"2026100105270889200_ref5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12929-025-01141-x","article-title":"Accelerating antibody discovery and optimization with high-throughput experimentation and machine learning","volume":"32","author":"Matsunaga","year":"2025","journal-title":"J Biomed Sci"},{"key":"2026100105270889200_ref6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13036-025-00513-z","article-title":"High-throughput strategies for monoclonal antibody screening: Advances and challenges","volume":"19","author":"Wang","year":"2025","journal-title":"J Biol Eng"},{"key":"2026100105270889200_ref7","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2020.1743053","volume-title":"mAbs","author":"Bailly","year":"2020"},{"key":"2026100105270889200_ref8","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2023.2200540","volume-title":"mAbs","author":"Jain","year":"2023"},{"key":"2026100105270889200_ref9","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1039\/D1CB00067E","article-title":"Aggregation of protein therapeutics enhances their immunogenicity: Causes and mitigation strategies","volume":"2","author":"Lundahl","year":"2021","journal-title":"RSC Chem Biol"},{"key":"2026100105270889200_ref10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.bej.2018.06.003","article-title":"Understanding and overcoming trade-offs between antibody affinity, specificity, stability and solubility","volume":"137","author":"Rabia","year":"2018","journal-title":"Biochem Eng J"},{"key":"2026100105270889200_ref11","doi-asserted-by":"publisher","first-page":"7436","DOI":"10.1093\/nar\/gky550","article-title":"High-throughput antibody engineering in mammalian cells by CRISPR\/Cas9-mediated homology-directed mutagenesis","volume":"46","author":"Mason","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2026100105270889200_ref12","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.chembiol.2021.05.019","article-title":"Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis","volume":"28","author":"Zupancic","year":"2021","journal-title":"Cell Chem Biol"},{"key":"2026100105270889200_ref13","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1021\/acssynbio.1c00512","article-title":"Engineering strategies to overcome the stability\u2013function trade-off in proteins","volume":"11","author":"Teufl","year":"2022","journal-title":"ACS Synth Biol"},{"key":"2026100105270889200_ref14","doi-asserted-by":"publisher","first-page":"16638","DOI":"10.1074\/jbc.M117.783837","article-title":"Arginine mutations in antibody complementarity-determining regions display context-dependent affinity\/specificity trade-offs","volume":"292","author":"Tiller","year":"2017","journal-title":"J Biol Chem"},{"key":"2026100105270889200_ref15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s12551-017-0288-0","article-title":"Searching for the pareto frontier in multi-objective protein design","volume":"9","author":"Nanda","year":"2017","journal-title":"Biophys Rev"},{"key":"2026100105270889200_ref16","doi-asserted-by":"publisher","first-page":"e1003988","DOI":"10.1371\/journal.pcbi.1003988","article-title":"Mapping the pareto optimal design space for a functionally deimmunized biotherapeutic candidate","volume":"11","author":"Salvat","year":"2015","journal-title":"PLoS Comput Biol"},{"key":"2026100105270889200_ref17","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1093\/bioinformatics\/btac020","article-title":"ProteinBERT: A universal deep-learning model of protein sequence and function","volume":"38","author":"Brandes","year":"2022","journal-title":"Bioinformatics"},{"key":"2026100105270889200_ref18","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1126\/science.ade2574","article-title":"Evolutionary-scale prediction of atomic-level protein structure with a language model","volume":"379","author":"Lin","year":"2023","journal-title":"Science"},{"key":"2026100105270889200_ref19","doi-asserted-by":"crossref","DOI":"10.1101\/2023.10.01.560349","article-title":"Saprot: protein language modeling with structure-aware vocabulary","volume-title":"International Conference on Learning Representations","author":"Su"},{"key":"2026100105270889200_ref20","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1093\/bioinformatics\/btac016","article-title":"ABlooper: Fast accurate antibody CDR loop structure prediction with accuracy estimation","volume":"38","author":"Abanades","year":"2022","journal-title":"Bioinformatics"},{"key":"2026100105270889200_ref21","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s42003-023-04927-7","article-title":"ImmuneBuilder: Deep-learning models for predicting the structures of immune proteins","volume":"6","author":"Abanades","year":"2023","journal-title":"Commun Biol"},{"key":"2026100105270889200_ref22","article-title":"Protein generation with evolutionary diffusion: sequence is all you need","volume-title":"NeurIPS 2023 Generative AI and Biology (GenBio) Workshop","author":"Alamdari"},{"key":"2026100105270889200_ref23","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41586-023-06415-8","article-title":"De novo design of protein structure and function with RFdiffusion","volume":"620","author":"Watson","year":"2023","journal-title":"Nature"},{"key":"2026100105270889200_ref24","volume-title":"ICLR 2024 Workshop on Generative and Experimental Perspectives for Biomolecular Design","author":"Cohen"},{"key":"2026100105270889200_ref25","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae304","article-title":"AttABseq: An attention-based deep learning prediction method for antigen\u2013antibody binding affinity changes based on protein sequences","volume":"25","author":"Jin","year":"2024","journal-title":"Brief Bioinform"},{"key":"2026100105270889200_ref26","doi-asserted-by":"publisher","first-page":"D545","DOI":"10.1093\/nar\/gkad1056","article-title":"The patent and literature antibody database (PLAbDab): An evolving reference set of functionally diverse, literature-annotated antibody sequences and structures","volume":"52","author":"Abanades","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"2026100105270889200_ref27","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1093\/bioinformatics\/btab762","article-title":"CSM-AB: Graph-based antibody\u2013antigen binding affinity prediction and docking scoring function","volume":"38","author":"Myung","year":"2022","journal-title":"Bioinformatics"},{"key":"2026100105270889200_ref28","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2022.2026208","volume-title":"mAbs","author":"Lai","year":"2022"},{"key":"2026100105270889200_ref29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semcancer.2023.06.005","volume-title":"Seminars in Cancer Biology","author":"Bai","year":"2023"},{"key":"2026100105270889200_ref30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12929-024-01018-5","article-title":"The rise of big data: Deep sequencing-driven computational methods are transforming the landscape of synthetic antibody design","volume":"31","author":"Gallo","year":"2024","journal-title":"J Biomed Sci"},{"key":"2026100105270889200_ref31","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1073\/pnas.1616408114","article-title":"Biophysical properties of the clinical-stage antibody landscape","volume":"114","author":"Jain","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"2026100105270889200_ref32","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1101\/2024.01.13.575504","article-title":"FLAb: benchmarking deep learning methods for antibody fitness prediction","author":"Chungyoun","year":"2024"},{"key":"2026100105270889200_ref33","doi-asserted-by":"publisher","article-title":"Fitness landscape for antibodies 2: benchmarking reveals thatm protein AI models cannot yet consistently predict developability properties","author":"Chungyoun","DOI":"10.64898\/2025.12.27.696706"},{"key":"2026100105270889200_ref34","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2025.2593055","article-title":"A high-throughput platform for biophysical antibody developability assessment to enable AI\/ML model training","volume":"17","author":"Arsiwala","year":"2025","journal-title":"mAbs"},{"key":"2026100105270889200_ref35","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s12539-024-00613-2","article-title":"DOTAD: A database of therapeutic antibody developability","volume":"16","author":"Li","year":"2024","journal-title":"Interdiscip Sci: Comput Life Sci"},{"key":"2026100105270889200_ref36","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2026.2623330","volume-title":"mAbs","author":"Czerwinski","year":"2026"},{"key":"2026100105270889200_ref37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/pro.4205","article-title":"Observed antibody space: A diverse database of cleaned, annotated, and translated unpaired and paired antibody sequences","volume":"31","author":"Olsen","year":"2022","journal-title":"Protein Sci"},{"key":"2026100105270889200_ref38","doi-asserted-by":"publisher","first-page":"bay040","DOI":"10.1093\/database\/bay040","article-title":"AbDb: Antibody structure database\u2014A database of PDB-derived antibody structures","volume":"2018","author":"Ferdous","year":"2018","journal-title":"Database"},{"key":"2026100105270889200_ref39","doi-asserted-by":"publisher","first-page":"D1140","DOI":"10.1093\/nar\/gkt1043","article-title":"SAbDab: The structural antibody database","volume":"42","author":"Dunbar","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2026100105270889200_ref40","doi-asserted-by":"publisher","first-page":"D383","DOI":"10.1093\/nar\/gkz827","article-title":"Thera-SAbDab: The therapeutic structural antibody database","volume":"48","author":"Raybould","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"2026100105270889200_ref41","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/bioinformatics\/btaa739","article-title":"CoV-AbDab: The coronavirus antibody database","volume":"37","author":"Raybould","year":"2021","journal-title":"Bioinformatics"},{"key":"2026100105270889200_ref42","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1021\/acssynbio.8b00407","article-title":"sdAb-DB: The single domain antibody database","volume":"7","author":"Wilton","year":"2018","journal-title":"ACS Synth Biol"},{"key":"2026100105270889200_ref43","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1093\/bioinformatics\/btac439","article-title":"Ab-CoV: A curated database for binding affinity and neutralization profiles of coronavirus-related antibodies","volume":"38","author":"Rawat","year":"2022","journal-title":"Bioinformatics"},{"key":"2026100105270889200_ref44","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1074\/mcp.M800264-MCP200","article-title":"Antibodypedia, a portal for sharing antibody and antigen validation data","volume":"7","author":"Bj\u00f6rling","year":"2008","journal-title":"Mol Cell Proteomics"},{"key":"2026100105270889200_ref45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/abt\/tbac029","article-title":"Developability assessment at early-stage discovery to enable development of antibody-derived therapeutics","volume":"6","author":"Zhang","year":"2023","journal-title":"Antib Ther"},{"key":"2026100105270889200_ref46","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2023.2171248","article-title":"Assessing developability early in the discovery process for novel biologics","volume":"15","author":"Fern\u00e1ndez-Quintero","year":"2023","journal-title":"MAbs"},{"key":"2026100105270889200_ref47","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1101\/2022.08.16.504181","volume-title":"bioRxiv","author":"Bachas","year":"2022"},{"key":"2026100105270889200_ref48","doi-asserted-by":"publisher","first-page":"btae268","DOI":"10.1093\/bioinformatics\/btae268","article-title":"AbLEF: Antibody language ensemble fusion for thermodynamically empowered property predictions","volume":"40","author":"Rollins","year":"2024","journal-title":"Bioinformatics"},{"key":"2026100105270889200_ref49","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1021\/acs.molpharmaceut.4c00804","article-title":"Machine learning models for predicting monoclonal antibody biophysical properties from molecular dynamics simulations and deep learning-based surface descriptors","volume":"22","author":"Wu","year":"2024","journal-title":"Mol Pharm"},{"key":"2026100105270889200_ref50","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1073\/pnas.1810576116","article-title":"Five computational developability guidelines for therapeutic antibody profiling","volume":"116","author":"Raybould","year":"2019","journal-title":"Proc Natl Acad Sci"},{"key":"2026100105270889200_ref51","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2025.2474521","volume-title":"mAbs","author":"Li","year":"2025"},{"key":"2026100105270889200_ref52","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2021.2020082","volume-title":"mAbs","author":"Khetan","year":"2022"},{"key":"2026100105270889200_ref53","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s13238-017-0408-4","article-title":"Pharmacokinetics of monoclonal antibodies and fc-fusion proteins","volume":"9","author":"Liu","year":"2018","journal-title":"Protein Cell"},{"key":"2026100105270889200_ref54","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2021.1932230","article-title":"Identifying biophysical assays and in silico properties that enrich for slow clearance in clinical-stage therapeutic antibodies","volume":"13","author":"Grinshpun","year":"2021","journal-title":"mAbs"},{"key":"2026100105270889200_ref55","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2026.2678000","volume-title":"mAbs","author":"Sakhnini","year":"2026"},{"key":"2026100105270889200_ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2022.100254","article-title":"Computational counterselection identifies nonspecific therapeutic biologic candidates","volume":"2","author":"Saksena","year":"2022","journal-title":"Cell Rep Methods"},{"key":"2026100105270889200_ref57","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41551-023-01074-6","article-title":"Optimization of therapeutic antibodies for reduced self-association and non-specific binding via interpretable machine learning","volume":"8","author":"Makowski","year":"2024","journal-title":"Nat Biomed Eng"},{"key":"2026100105270889200_ref58","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1080\/19420862.2015.1007828","volume-title":"mAbs","author":"Obrezanova","year":"2015"},{"key":"2026100105270889200_ref59","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1021\/acs.molpharmaceut.6b00071","article-title":"Measurements of monoclonal antibody self-association are correlated with complex biophysical properties","volume":"13","author":"Geng","year":"2016","journal-title":"Mol Pharm"},{"key":"2026100105270889200_ref60","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1038\/s41467-023-37668-6","article-title":"Automated optimisation of solubility and conformational stability of antibodies and proteins","volume":"14","author":"Rosace","year":"2023","journal-title":"Nat Commun"},{"key":"2026100105270889200_ref61","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.3389\/fimmu.2019.02921","article-title":"Molecular landscape of anti-drug antibodies reveals the mechanism of the immune response following treatment with TNF$\\alpha$ antagonists","volume":"10","author":"Vaisman-Mentesh","year":"2019","journal-title":"Front Immunol"},{"key":"2026100105270889200_ref62","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-1859-2_3","volume-title":"Insoluble Proteins","author":"Pujols","year":"2022"},{"key":"2026100105270889200_ref63","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/19420862.2015.1099773","volume-title":"mAbs","author":"Agrawal","year":"2016"},{"key":"2026100105270889200_ref64","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1016\/j.csbj.2022.04.035","article-title":"DeepSCM: An efficient convolutional neural network surrogate model for the screening of therapeutic antibody viscosity","volume":"20","author":"Lai","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"key":"2026100105270889200_ref65","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/bioinformatics\/btz773","article-title":"SOLart: A structure-based method to predict protein solubility and aggregation","volume":"36","author":"Hou","year":"2020","journal-title":"Bioinformatics"},{"key":"2026100105270889200_ref66","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1093\/bioinformatics\/btp386","article-title":"SOLpro: Accurate sequence-based prediction of protein solubility","volume":"25","author":"Magnan","year":"2009","journal-title":"Bioinformatics"},{"key":"2026100105270889200_ref67","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/bioinformatics\/btx662","article-title":"PaRSnIP: Sequence-based protein solubility prediction using gradient boosting machine","volume":"34","author":"Rawi","year":"2018","journal-title":"Bioinformatics"},{"key":"2026100105270889200_ref68","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2022.2163584","volume-title":"mAbs","author":"Harmalkar","year":"2023"},{"key":"2026100105270889200_ref69","doi-asserted-by":"publisher","first-page":"19074","DOI":"10.1038\/s41598-024-70101-6","article-title":"TEMPRO: Nanobody melting temperature estimation model using protein embeddings","volume":"14","author":"Alvarez","year":"2024","journal-title":"Sci Rep"},{"key":"2026100105270889200_ref70","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.ekir.2022.01.1073","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of VIS649 (sibeprenlimab), an APRIL-neutralizing IgG2 monoclonal antibody, in healthy volunteers","volume":"7","author":"Mathur","year":"2022","journal-title":"Kidney Int Rep"},{"key":"2026100105270889200_ref71","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s40425-019-0586-0","article-title":"Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics","volume":"7","author":"Davda","year":"2019","journal-title":"J Immunother Cancer"},{"key":"2026100105270889200_ref72","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.3389\/fimmu.2020.01951","article-title":"The molecular mechanisms that underlie the immune biology of anti-drug antibody formation following treatment with monoclonal antibodies","volume":"11","author":"Vaisman-Mentesh","year":"2020","journal-title":"Front Immunol"},{"key":"2026100105270889200_ref73","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.coi.2021.06.003","article-title":"New insights into b cells as antigen presenting cells","volume":"70","author":"Ghosh","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"2026100105270889200_ref74","doi-asserted-by":"publisher","first-page":"W502","DOI":"10.1093\/nar\/gkz452","article-title":"IEDB-AR: Immune epitope database\u2014Analysis resource in 2019","volume":"47","author":"Dhanda","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2026100105270889200_ref75","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2024.2333729","volume-title":"mAbs","author":"Mattei","year":"2024"},{"key":"2026100105270889200_ref76","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1093\/bioinformatics\/btab434","article-title":"Humanization of antibodies using a machine learning approach on large-scale repertoire data","volume":"37","author":"Marks","year":"2021","journal-title":"Bioinformatics"},{"key":"2026100105270889200_ref77","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2021.2020203","volume-title":"mAbs","author":"Prihoda","year":"2022"},{"key":"2026100105270889200_ref78","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1101\/2025.08.14.670305","article-title":"Antibody immunogenicity prediction and optimization with ImmunoSeq","author":"Huang","year":"2025"},{"key":"2026100105270889200_ref79","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/bit.70086","article-title":"AB-panda: An AI-generated antibody structure-based tool for developability prediction","volume":"123","author":"Zou","year":"2025","journal-title":"Biotechnol Bioeng"},{"key":"2026100105270889200_ref80","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2025.2472009","volume-title":"mAbs","author":"Sweet-Jones","year":"2025"},{"key":"2026100105270889200_ref81","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.2112.07782","article-title":"Deciphering antibody affinity maturation with language models and weakly supervised learning","author":"Ruffolo","year":"2021"},{"key":"2026100105270889200_ref82","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2024.2362788","article-title":"Molecular surface descriptors to predict antibody developability: Sensitivity to parameters, structure models, and conformational sampling","volume":"16","author":"Park","year":"2024","journal-title":"MAbs"},{"key":"2026100105270889200_ref83","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1039\/D3DD00227F","article-title":"Pareto optimization to accelerate multi-objective virtual screening","volume":"3","author":"Fromer","year":"2024","journal-title":"Dig Dis"},{"key":"2026100105270889200_ref84","first-page":"1321","volume-title":"Proceedings of the 34th international conference on machine learning","author":"Guo","year":"2017"},{"key":"2026100105270889200_ref85","first-page":"2796","volume-title":"Proceedings of the 35th international conference on machine learning","author":"Kuleshov","year":"2018"},{"key":"2026100105270889200_ref86","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2022.100374","article-title":"Toward real-world automated antibody design with combinatorial bayesian optimization","volume":"3","author":"Khan","year":"2023","journal-title":"Cell Rep Methods"},{"key":"2026100105270889200_ref87","volume-title":"ICLR 2024 Workshop on Generative and Experimental Perspectives for Biomolecular Design","author":"Zeng","year":"2024"},{"key":"2026100105270889200_ref88","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.2412.07763","article-title":"Bayesian optimization of antibodies informed by a generative model of evolving sequences","author":"Amin","year":"2024"},{"key":"2026100105270889200_ref89","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.2201.12570","article-title":"Antbo: towards real-world automated antibody design with combinatorial bayesian optimisation","author":"Khan","year":"2022"},{"key":"2026100105270889200_ref90","doi-asserted-by":"publisher","first-page":"6636","DOI":"10.1021\/acs.molpharmaceut.5c00591","article-title":"Bayesian optimization for efficient multiobjective formulation development of biologics","volume":"22","author":"Waibel","year":"2025","journal-title":"Mol Pharm"},{"key":"2026100105270889200_ref91","doi-asserted-by":"publisher","first-page":"e04350","DOI":"10.1002\/advs.202504350","article-title":"RESP2: An uncertainty aware multi-target multi-property optimization AI pipeline for antibody discovery","volume":"12","author":"Parkinson","year":"2025","journal-title":"Adv Sci"},{"key":"2026100105270889200_ref92","doi-asserted-by":"publisher","first-page":"11543","DOI":"10.1021\/acs.jcim.5c01577","article-title":"ALLM-ab: Active learning-driven antibody optimization using fine-tuned protein language models","volume":"65","author":"Furui","year":"2025","journal-title":"J Chem Inf Model"},{"key":"2026100105270889200_ref93","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2025.2584935","volume-title":"mAbs","author":"Pereira","year":"2025"},{"key":"2026100105270889200_ref94","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.2507.02670","article-title":"Guided generation for developable antibodies","author":"Zhao","year":"2025"},{"key":"2026100105270889200_ref95","volume-title":"International Conference on Learning Representations","author":"Ren","year":"2025"},{"key":"2026100105270889200_ref96","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2024.2394229","volume-title":"mAbs","author":"Amash","year":"2024"},{"key":"2026100105270889200_ref97","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-026-09594-y","article-title":"Characterising nanobody developability to improve therapeutic design using the therapeutic nanobody profiler","volume":"9","author":"Gordon","year":"2026","journal-title":"Commun Biol"},{"key":"2026100105270889200_ref98","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2024.2403156","article-title":"A comparative study of the developability of full-length antibodies, fragments, and bispecific formats reveals higher stability risks for engineered constructs","volume":"16","author":"Condado-Morales","year":"2024","journal-title":"mAbs"},{"key":"2026100105270889200_ref99","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2025.2479531","volume-title":"mAbs","author":"Barlow","year":"2025"},{"key":"2026100105270889200_ref100","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2024.PA2983","article-title":"A long-acting high affinity anti-TSLP antibody (GB-0895) for severe asthma identified leveraging a proprietary machine learning platform.","volume":"64","author":"Gawde","journal-title":"European Respiratory Journal"},{"key":"2026100105270889200_ref101","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/prot.70076","article-title":"Progress and bottlenecks for deep learning in computational structure biology: CASP round XVI","volume":"94","author":"Kryshtafovych","year":"2025","journal-title":"Proteins"},{"key":"2026100105270889200_ref102","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2026.01.012","article-title":"LUMI-lab: a foundation model-driven autonomous platform enabling discovery of new ionizable lipid designs for mRNA delivery","volume-title":"Cell","author":""}],"container-title":["Antibody Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/abt\/advance-article-pdf\/doi\/10.1093\/abt\/tbag039\/70410162\/tbag039.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/abt\/article-pdf\/9\/4\/508\/70410162\/tbag039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/abt\/article-pdf\/9\/4\/508\/70410162\/tbag039.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:27:17Z","timestamp":1790846837000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/abt\/article\/9\/4\/508\/8748294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":102,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/abt\/tbag039","relation":{},"ISSN":["2516-4236"],"issn-type":[{"value":"2516-4236","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,7,31]]}}}